These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9506572)

  • 1. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage.
    Schmitt WH; Csernok E; Kobayashi S; Klinkenborg A; Reinhold-Keller E; Gross WL
    Arthritis Rheum; 1998 Mar; 41(3):445-52. PubMed ID: 9506572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity.
    D'Cruz D; Direskeneli H; Khamashta M; Hughes GR
    J Rheumatol; 1999 Jan; 26(1):103-9. PubMed ID: 9918249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of soluble interleukin-2 receptor in patients with ANCA-associated vasculitis.
    Arranz O; Ara J; Rodríguez R; Saurina A; Mirapeix E; Darnell A
    J Nephrol; 2000; 13(1):59-64. PubMed ID: 10720216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome--62 patients.
    Guillevin L; Visser H; Noel LH; Pourrat J; Vernier I; Gayraud M; Oksman F; Lesavre P
    J Rheumatol; 1993 Aug; 20(8):1345-9. PubMed ID: 7901412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
    Dejica D
    Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides.
    Boehme MW; Schmitt WH; Youinou P; Stremmel WR; Gross WL
    Am J Med; 1996 Oct; 101(4):387-94. PubMed ID: 8873509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum eosinophil cationic protein: a marker of disease activity in Churg-Strauss syndrome.
    Guilpain P; Auclair JF; Tamby MC; Servettaz A; Mahr A; Weill B; Guillevin L; Mouthon L
    Ann N Y Acad Sci; 2007 Jun; 1107():392-9. PubMed ID: 17804567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome.
    Sinico RA; Di Toma L; Maggiore U; Bottero P; Radice A; Tosoni C; Grasselli C; Pavone L; Gregorini G; Monti S; Frassi M; Vecchio F; Corace C; Venegoni E; Buzio C
    Arthritis Rheum; 2005 Sep; 52(9):2926-35. PubMed ID: 16142760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study on five myeloperoxidase specific anti-neutrophil cytoplasmic antibody (MPO-ANCA) positive Churg-Strauss syndrome cases].
    Yoshihara K; Arimura Y; Kobayashi O; Minoshima S; Kobayashi M; Yomogita S; Soejima A; Nakabayashi K; Kitamoto K; Nagasawa T
    Ryumachi; 1998 Oct; 38(5):696-704. PubMed ID: 9852746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
    Bodey B; Psenko V; Lipsey AL; Kaiser HE
    Anticancer Res; 1996; 16(1):219-24. PubMed ID: 8615612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble serum interleukin 2 receptors in patients with systemic sclerosis.
    Steen VD; Engel EE; Charley MR; Medsger TA
    J Rheumatol; 1996 Apr; 23(4):646-9. PubMed ID: 8730120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell activation in patients with ANCA-associated vasculitis: inefficient immune suppression by therapy.
    Christensson M; Pettersson E; Sundqvist KG; Christensson B
    Clin Nephrol; 2000 Dec; 54(6):435-42. PubMed ID: 11140803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels.
    Polisson RP; Gilkeson GS; Pyun EH; Pisetsky DS; Smith EA; Simon LS
    J Rheumatol; 1996 Apr; 23(4):654-8. PubMed ID: 8730122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble interleukin 2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in patients with systemic lupus erythematosus.
    Raziuddin S; al-Janadi MA; al-Wabel AA
    J Rheumatol; 1991 Jun; 18(6):831-6. PubMed ID: 1680190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell and eosinophil activation in mild and moderate atopic and nonatopic children's asthma in remission.
    Pumputiene I; Emuzyte R; Dubakiene R; Firantiene R; Tamosiunas V
    Allergy; 2006 Jan; 61(1):43-8. PubMed ID: 16364155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum high mobility group box-1 level in Churg-Strauss syndrome.
    Taira T; Matsuyama W; Mitsuyama H; Kawahara KI; Higashimoto I; Maruyama I; Osame M; Arimura K
    Clin Exp Immunol; 2007 May; 148(2):241-7. PubMed ID: 17437420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients.
    Zailaie MZ
    Saudi Med J; 2005 Jul; 26(7):1085-91. PubMed ID: 16047057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-endothelial cell antibodies in antineutrophil cytoplasmic antibodies negative pauci-immune crescentic glomerulonephritis.
    Cong M; Chen M; Zhang JJ; Hu Z; Zhao MH
    Nephrology (Carlton); 2008 Jun; 13(3):228-34. PubMed ID: 18315705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo.
    Merkel PA; Dooley MA; Dawson DV; Pisetsky DS; Polisson RP
    J Rheumatol; 1996 Nov; 23(11):1856-61. PubMed ID: 8923356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum soluble CD4 and CD8 levels in polymyalgia rheumatica.
    Salvarani C; Boiardi L; Macchioni P; Casadei Maldini M; Mancini R; Beltrandi E; Rossi F; Portioli I
    J Rheumatol; 1994 Oct; 21(10):1865-9. PubMed ID: 7837152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.